| Important Deadlines |
| Abstract
Submission Deadline/Online |
| September 1,
2005 |
| Abstract
Submission Deadline/Hard Copy |
| July 15, 2005 |
| Early
Pre-Registration Deadline |
| August 15, 2005 |
| Abstract
Acceptance Notification Deadline |
| September 1, 2005 |
| Hotel
Accommodation Cancellation Deadline |
| September 10, 2005 |
| Conference
Registration Cancellation Deadline |
| September 30, 2005 |
| Late
Pre-Registration Deadline |
| October 15, 2005 |
|
| November 10, Thursday |
|
| 9.00 – 9.30 |
Opening Ceremony Ball Room |
| |
Bülent Berkarda
President, Turkish Society of Chemotherapy
Kurt Naber
President, International Society of Chemotherapy
Jean-Claude Pechère
Past President, International Society of Chemotherapy |
| 9.30 – 10.30 |
Session I Ballroom |
| Chair Persons : |
Dinçer Fırat , Ankara –Turkey
Jean
Claude Pechère, Geneva - Switzerland
|
| 9:30 – 10:00 |
Epidemiology of Cancer in Turkey
A. Murat Tuncer
Ankara, Turkey |
| 10:00 – 10:30 |
Targeted Therapies in Cancer
Emin Kansu
Ankara, Turkey |
| 10:30 – 10:45 |
Coffee Break |
| 10:45 – 12:45 |
Session II Ballroom |
| Chair Persons: |
Teresita Mazzei, Florence – Italy
Fikri İçli , Ankara - Turkey
|
| 10:45 – 11:15 |
Cell Language
Jean-Claude Pechère
Geneva, Switzerland |
| 11:15 – 11:45 |
Progress in Medical Cancer Therapy
Bernard Hoerni
Bordeaux, France |
| 11:45 – 12:15 |
Basics of Anticancer Therapeutical Agents:
Molecular Pharmacology of Drug Resistance and Its
Circumvention
Erdem Göker
Izmir, Turkey |
| 12:15 – 12:45 |
Molecular Factors Which Influence the Sensitivity to
EGFR-TKI
Kazuto Nishio
Tokyo, Japan |
| 12:45 – 14:00 |
Lunch |
| 14:00 – 15:30 |
Session III Ballroom |
| Chair Persons: |
Kurt Naber, Straubing - Germany
Haluk Onat, İstanbul - Turkey
|
| 14:00 – 14:30 |
Treatment Of Neuroendocrine Tumors
Şuayip Yalçın
Ankara, Turkey
(Sponsored by Novartis) |
| 14:30 – 15:00 |
The Autologous Hemopoietic Stem Cell Transplantation
in Adult
Patients with Lymphoma. Turkish Bone Marrow Transplantation
Registry Results
Selmin Ataergin
Ankara, Turkey |
| 15:00 – 15:30 |
Adjuvant Treatment in Early Breast Cancer
Evin Büyükünal
(Sponsored by Sanofi - Aventis) |
| 15:30 – 15:45 |
Coffee Break |
| 15:45 – 17:15 |
Session IV Ballroom |
| Chair Persons: |
Necdet Üskent, Gebze, Kocaeli - Turkey
Münir Kınay, İzmir - Turkey |
| 15:45 – 16:15 |
Multiple Myeloma - Bortezomib: New Option
(Sponsored by Janssen Cilag) |
| 16:15 – 16:45 |
Pharmacogenomic Determinants of Efficacy
and Toxicity of
Anticancer Drugs
Enrico Mini
Florence, Italy |
| 16:45 – 17:15 |
A Paradigm Shift from Chemotherapy
Josep Tabernero
Barcelona, Spain
(Sponsored by Merck) |
| 17:15 – 18:15 |
Session V Ballroom |
| |
S – I SYMPOSIUM: Multi-Targeted Approach to Cancer
(Sponsored by Pfizer)
Moderator : Nil Molinas Mandel
İstanbul, Turkey
S- I A The Evolving Paradigm in the Treatment of GIST - TBD
S- I B The Future of RCC With Targeted Therapies
Daniel George
Durham, USA |
| 19:30 - 21:30 |
WELCOME RECEPTION
Opera Room - The Marmara Hotel, lobby level |
| Friday, November 11, 2005 |
|
| 8:30 – 10:30 |
Session VI Ballroom |
| Chair Persons: |
Süheyla Serdengeçti, İstanbul – Turkey
Gökhan Demir, İstanbul - Turkey |
| 8:30 – 9:00 |
Beta Glucan Induces "in vivo" Expression
of Fas (CD95) on Peripheral
Blood
Monocytes in Breast Cancer Patients
Gökhan Demir
Istanbul / Turkey
|
| 9:00 – 9:30 |
Adjuvant Chemotherapy in Non-Small Cell lung Cancer
Ronald Feld
Canada |
| 9:30 – 10:00 |
Treatment of High-grade Gliomas
Michael Weller
Tübingen, Germany
(Sponsored by Schering Plough) |
| 10:00 – 10:30 |
Role of Anti-Angiogenic Therapy in Colo-Rectal Cancer
Treatment
Fuat Demirelli
Istanbul, Turkey
(Sponsored by Roche) |
| 10:30 – 10:45 |
Coffee break |
| 10:45 – 12:45 |
Session VII Ballroom |
| Chair Persons: |
Abraham Kuten, Tel Aviv - Israel
Mahmut Özşahin, Lausanne - Switzerland |
| 10:45 – 11:15 |
An Old-New Strategy of Chemotherapy. Metronomic
Administration of Cytostatic Drugs Illustrated by the Example
of Low-Dose Cyclophosphamide Suppression of Regulatory
CD4 Lymphocytes and of Tumor Neo-Angiogenesis
H. Otto Klein and Gokhan Demir
Cologne, Germany and Istanbul, Turkey |
| 11:15 – 11:45 |
Concomitant Radio-Hormonotherapy as Adjuvant
in Early Breast Cancer
David Azria
Montpellier, France |
| 11:45 – 12:15 |
Approaches to Cancer Prevention Based on
Understanding of Chemical Carcinogenesis
Emel Arınç
Ankara, Turkey |
| 12.15 – 12:45 |
Is There a Future in Cancer Gene Therapy?
Hakan Akbulut
Ankara, Turkey |
| 12:45 – 14:00 |
Lunch |
| 14:00 – 15:30 |
Session VIII Ball Room |
| Chair Persons: |
Ronald Feld , Toronto - Canada
Evin Büyükünal, İstanbul - Turkey
|
| 14.00 – 14:30 |
Extramedullary Localizations of Acute Myeloblastic
Leukemia
Ayhan O. Çavdar
Ankara, Turkey |
| 14:30 – 15:00 |
Prognostic Factors and Recursive Partitioning
Analysis in Glioblastoma Treated by Radiotherapy and Temezolomide
René Olivier Mirimanoff
Lausanne, Switzerland |
| 15.00 – 15.30 |
Adjuvant Treatment of High-Risk Head and
Neck Cancer Following Curative Surgery
Mahmut Özşahin
Lausanne, Switzerland |
| 15.30 – 15.45 |
Coffee break |
| 15.45 – 17.45 |
Session IX Ball Room |
| Chair Persons: |
Fuat Demirelli, İstanbul – Turkey
Semra Paydaş, Adana - Turkey |
| 15:45 – 16:15 |
Combined Modality Therapy in Aggressive
non-Hodgkin’s Gastric Lymphoma
Abraham Kuten
Tel Aviv, Israel |
| 16.15- 16:45 |
Systemic Therapies and Radiation Therapy
Combinations in Head and Neck Cancer
Mehmet Şen
Leeds, UK |
| 16:45 – 17:15 |
Palliative Care in Cancer
Şeref Kömürcü
Ankara, Turkey |
| 17:15 – 17:30 |
Second Neoplasms in Long Survivors of Childhood
Hodgkins Disease
Emel Ünal
Ankara, Turkey |
| 17:30 – 17:45 |
From Tuberculosis to Cancer The Conversion
of an Anti-Tbc Agent into a Potential Cancer Drug
Bert Klebl
Munich, Germany |
| Friday, November 11, 2005 |
|
| 11:15 –12:40 |
Session X Opera Room |
| |
Poster Session I
Moderator: Pınar Saip
Istanbul, Turkey
|
PO I / 1
CLINICAL AND EPIDEMIOLOGICAL APPROACH OF THE MALIGNAN PLEURAL
MESOTHELIOMA IN THE REGION OF ORAN
B. Ziane, S. Lellou, Y. Berrabab / Algeria
PO I / 2
COMPARATION OF PHENOTYPIC MARKERS OF MIELANOCYTIC DENDRITIC
CELLS FROM MELANOMA PATIENTS AND HEALTHY CONTROLS
Javıer Godino(1), Jose Mayordomo(1), Ivan Marcos(1),
Raquel
Andres(1), Julio Lambea(1), C Visus(2), Rodrigo Lastra(1),
Eugenıa
Ortega(1), Elena Aguırre(1), Esther Millastre(1), Manuel
Ruız-Echarrı(1), Alejandro Tres(1)
(1) Spain, (2) USA
PO I / 3
OBSERVED IMMEDIATE RESULTS OF PROXIMAL AND DISTAL PANCREATECTOMY
DURING THE FIFTEEN YEARS TIME PERIOD
Modassar T. Awan , Igor V. MICHAILOV , Vladimir M. BONDARENKO
/ Belarus
PO I / 4
NEPHROTOXICITY, CARDIOTOXICITY AND ANEMIA RELATIONED
WITH CONTINUEDTREATMENT OF TRASTUZUMAB.
Julio Lambea, E. Ortega, R. Lastra, E. Aguirre, E. Millastre,
M. Ruiz-Echarri, JI.
Mayordomo, P. Escudero, R. Andres, D. Isla, A. Saenz-Cusi
, A. Tres / Spain
PO I / 5
RENAL CELL CANCER: THERAPEUTIC TARGETS
Julio Lambea(1), R. Lastra(1), E. Ortega(1), E. Aguirre(1),
E. Millastre(1), M. Ruiz-Echarri(1), JI.
Mayordomo(1), J. Godino(1), I. Marcos(1), R. Andres(1),
D. Isla(1), P. Escudero(1), A.
Saenz-Cusi(1), W. Storkus(2), A. Tres (1)
(1) Zaragoza - Spain
(2) Pittsburgh - USA
PO I / 6
AMIFOSTINE MAY PROVIDE PARTIAL SYMPTOMATIC AND CLINICAL
AMELIORATONIN REFRACTORY ANEMIA
Selmin ATAERGIN, Fikret ARPACI, Turker CETIN / Turkey
PO I / 7
DONOR CELL PHILADELPHIA (PH) CHROMOSOME (-) LEUKEMIA
IN A PATIENT WITH
PH (+) CHRONIC MYELOID LEUKEMIA (CML) UNDERGOING ALLOGENEIC
BONE
MARROW TRANSPLANTATION (BMT)
Selmin ATAERGIN, Fikret ARPACI, Cuneyt ULUTIN, Turker
CETIN, Ahmet OZET / Turkey
PO I / 8
A RARE PRESENTATION OF NON-HODGKİN’S LYMPHOMA WİTH NASOPHARYNX
INVOLVEMENT WHO RELAPSED AFTER AUTOLOGOUS PERIPHERAL
BLOOD STEM
CELL TRANSPLANTATION (PBSCT)
Selmin ATAERGIN, Ahmet OZET, Cuneyt ULUTIN, Fikret ARPACI,
Seref KOMURCU / Turkey
PO I / 9
METASTASES OF PANCREATIC TAIL CARCINOMA INTO UROGENITAL
ORGANS
Milena ZAMUROVIC, Pavle SRBINOVIC, Jovana PETROVIC /
Serbia and Montenegro
PO I / 10
A NEW EFFECTIVE REMEDY FOR MALIGNANT GROWTH INHIBITION
Suslov Evgeny / Ukraine
PO I / 11
THE INTERRELATION BETWEEN DNA PLOIDY AND TREATMENT COURSES
OF SOME
HUMAN MALIGNANT TUMORS
Nikolaeva, T.G., Letiagin V.P., Krutii C.V., Polotskii
B.E. , Achundov A.A./ Russia
PO I / 12
CLONING OF ANTI-HBsAG SINGLE CHAIN VARIABLE FRAGMENTS
FOR TARGETTED
INTRACELLULAR IMMUNTHERAPY
Berrin Erdağ, Koray Balcıoğlu, Aylin Özdemir, Fatma
Yücel, Aynur Başalp,
Beyazıt Çırakoğlu / Türkiye
PO I / 13
BEHAVIOURAL AND IMMUNOHISTOLOGICAL ASSESSMENT IN TWO
ANIMAL MODELSOF OXALIPLATIN-INDUCED NEUROPATHY
Nicolas AUTHIER, Bing LING, David BALAYSSAC, Alain Alain
ESCHALIER, François COUDORE / France
PO I / 14
SECOND LINE OF TREATMENT OF METASTATIC MELANOMA WITH
TEMOZOLOMIDE:
A SINGLE INSTITUTION EXPERIENCE
AGUIRRE ELENA, ANDRES RAQUEL, MAYORDOMO JOSE IGNACIO,
LAMBEA
JULIO JOSÉ, LASTRA RODRIGO, ORTEGA EUGENIA, MILLASTRE
ESTHER,
RUIZ-ECHARRI MANOLO, TRES ALEJANDRO / Spain
PO I / 15
TUMOR MARKERS IN MELANOMA: COMPARATION BETWEEN TYROSINASE
AND S100
PROTEIN (PS100)
AGUIRRE ELENA, ANDRES RAQUEL, LAMBEA JULIO JOSE, LASTRA
RODRIGO, ORTEGA MARIA EUGENIA, RUIZ-ECHARRI MANOLO, MAYORDOMO
JOSE IGNACIO, MILLASTRE ESTHER, JAVIER GODINO, MARCOS
IVAN, TRES
ALEJANDRO / Spain
PO I / 16
DEVELOPMENT OF AN EXPRESSION SYSTEM OF PICHIA PASTORIS
TO PRODUCE A
RIBOSOME INACTIVATING PROTEIN (SAPORIN) AND FULLY RECOMBINANTS
SAPORIN-BASED IMMUNOTOXINS
Roberta TRAINI, Teresa Lopardo, Erika Barison, Pietro
Argeo Della Cristina,
M.Serena Fabbrini, Aldo Ceriotti, Marco Colombatti /
Italy
PO I / 17
FEW DETERMINATIONS OF S -100B PROTEIN AS A PREDICTOR
OF RELAPSE DURING FOLLOW UP IN PATIENTS WITH MELANOMA
Lastra Rodrigo, Andres Raquel, Ortega Eugenia, Aguirre
Elena, Lambea Julio,
Ruiz Echarri Manuel, Millastre Esther, Godino Javier,
Marcos Ivan, Tres Alejandro / Spain
PO I / 18
A PHASE II RANDOMIZED TRIAL OF DOXORUBICIN (DXR) AND
GEMCITABINE (GMZ)
ADMINISTERED IN PATIENTS WITH METASTATIC BREAST CANCER
(MBC)
Assia Bensalem / Algeria
PO I / 19
DOXORUBICINE – CISPLATIN IN UNDIFFERENTIATED CARCINOMA
OF NASOPHARYNGEAL TUMOR
(UCNT). WHICH RESULTS?
Assia Bensalem / Algeria
PO I / 20
SALIVA ONCOTEST – ONE OF THE INFORMATIVE DIAGNOSTIC METHODS
Suslov Evgeny / Ukraine
PO I / 21
CERULOPLASMIN CONTENT IN VARIOUS MALIGNANT DISEASES
Jovanna Petrovic / Serbia and Montenegro |
| 12:45 – 14:00 |
Lunch |
| 14:00 – 15:00 |
Session XI Opera Room |
S - II |
SYMPOSIUM: Infections and Cancer
Moderator: Murat Akova
Ankara – Turkey
S – II A Empirical Therapy of Febrile Neutropenia in Patients with
Cancer
Murat Akova, Ankara - Turkey
S – II B Risk Stratification in Febrile Neutropenia
Hamdi Akan, Ankara – Turkey
S – II C Treatment of Fungal Infections in Cancer Patients
George Petrikkos, Athens – Greece |
| 15:00 – 17:00 |
Session XII Opera Room |
| Chair Persons: |
Faruk Aykan, İstanbul – Turkey
Krassimir Metodiev, Sofia – Bulgaria
|
| 15:00 – 15:30 |
Prevention in Breast Cancer
Gül Başaran
İstanbul, Turkey |
| 15:30 – 16:00 |
Coffee Break |
| 16:00 – 16:30 |
Anticoagulants in the Treatment of Cancer
Özlem Er
Kayseri, Turkey |
| 16:30 – 17:00 |
Beyond the Targeted Therapies in Colo –
Rectal Cancer
Erdem Göker
İzmir, Turkey |
| 17:00 – 18:00 |
Session XIII Opera Room |
| 17:00 – 18:00 |
Poster Session II
Moderator: Bülent Berkarda
Istanbul, Turkey |
PO II / 22
GEFITINIB (IRESSA) AS A SECOND-LINE TREATMENT FOR ADVANCED
NON-SMALL CELL LUNG CANCERPATIENTS WHO FAILED FIRST-LINE
CHEMOTHERAPY IN KOREA
Byeong-Bae Park, Joon Oh Park, Sang We Kim, Joo Hang
Kim, Sang Won Shin,
Myung Ju Ahn, Jin Hyuck Choi, Jong Seog Lee, Keunchil
Park / Korea
PO II / 23
CETUXIMAB PLUS IRINOTECAN IN REFRACTORY METASTATİC COLORECTAL
CANCER
Bulent KARABULUT, Serkan OCAKCI, Ruchan USLU, Ulus A.
SANLI, Erhan
GOKMEN, Erdem GOKER / Turkey
PO II / 24
ARSENIC TRIOXIDE (AS2O3) EXPOSURE TO OVARIAN CARCINOMA
CELLS LEADS TO
DECREASED LEVEL OF TOPOISOMERASE II AND CYTOTOXICITY
Niyazi ASKAR, Erzat TOPRAK, Bulent KARABULUT, Nur SELVI,
Mustafa
TEREK, Ruchan USLU, Ulus A. SANLI, Erdem GOKER / Turkey
PO II / 25
THE EFFICACY AND TOLERABILITY OF CAPACITABINE IN METASTATIC
COLORECTAL CANCER
Ercument CENGIZ, Bulent KARABULUT, Yuksel KUCUKZEYBEK,
Burcak
KARACA, Rushan USLU, Ulus A. SANLI, Erhan GOKMEN, Erdem
GOKER / Turkey
PO II / 26
FLUOROURACIL AND FOLINIC ACID BOLUS SCHEDULE (NORDIC
REGIMEN)
COMBINED WITH IRINOTECAN AS A FIRST – LINE CHEMOTHERAPY
IN METASTATIC COLORECTAL CANCER
Bulent KARABULUT, Halit YETIS, Ulus.A SANLI, Ruchan
USLU, Adam USLU,
Erdem GOKER / Turkey
PO II / 27
CONTROLLED RELEASE OF METHOTREXATE FROM W/O MICROEMULSION
AND ITS
IN VITRO ANTI-TUMOR ACTIVITY
H. Yesim KARASULU, Bulent KARABULUT, Ruchan USLU, Ulus
A. SANLI, Erdem GOKER,
Taner GUNERI / Turkey
PO II / 28
THE EFFICACY AND TOLERABILITY OF CISPLATIN AND DOXORUBICIN
COMBINATION REGIMEN AS A NEO - ADJUVANT THERAPY OF OSTEOGENIC
SARCOMA
Bulent KARABULUT, Ruchan USLU, Ulus A. SANLI, Aysenur
MEMIS,
Taner AKALIN, Dundar SABAH, Guven YUCETURK, Erdem GOKER
/ Turkey
PO II / 29
ARSENIC TRIOXIDE – LOADED MICROEMULSION ENHANCED CYTOTOXICITY
ON MDAH 2774 OVARIAN CARCINOMA CELL LINE
Mustafa TEREK, Bulent KARABULUT, Nur SELVI, Levent AKMAN,
Yesim KARASULU, Ulus A. SANLI, Ruchan USLU, Erdem GOKER,
Aydin OZSARAN / Turkey
PO II / 30
THE IMPACT OF SPLENECTOMY ON SURVIVAL OF GASTRIC CANCER
PATIENTS
Rahşan GÜNDOĞAN, Haluk SAYAN, F. İlknur AYTAŞ, Nalan
ASLAN, Ferdi
AKSARAY, Mübeccel TÜMÖZ / Turkey
PO II / 31
NON-HODGKIN’S LYMPHOMA LOCALIZED IN ANORECTAL REGION
Mübeccel TÜMÖZ, F. İlknur AYTAŞ, Rahşan GÜNDOĞAN, Nalan
ASLAN, Haluk SAYAN / Turkey
PO II / 32
PULMONARY PLEOMORPHIC CARCINOMA : A CASE REPORT
F. İlknur AYTAŞ, Rahşan GÜNDOĞAN, Züleyha SAVAŞ, Sercan
ÖZYURT,
Mübeccel TÜMÖZ / Turkey
PO II / 33
THE RELATIONSHIP BETWEEN THE PAIN OF SKELETAL METHASTASIS
AND
RADIOTHERAPY
Melek YILMAZER, Sercan ÖZYURT, F. İlknur AYTAŞ, Rahşan
GÜNDOĞAN, Nalan ASLAN,
Mübeccel TÜMÖZ / Turkey
PO II / 34
LOW DOSE SINGLE AGENT ESTRAMUSTINE IN METASTATIC HORMONE
REFRACTORY PROSTATE CANCER(HRPC)
Wilmosh Mermershtain, Endre Neulander, Samuel Ariad
/ Israel
PO II / 35
GEFITINIB IN PRETREATED PATIENTS WITH ADVANCED NON-SMALL
CELL LUNG
CANCER – SINGLE INSTITUTION EXPERIENCE.
Irina Lazarev, Julia Dudnik, Samuel Ariad, Wilmosh Mermershtain
/ Israel
PO II / 36
99MTC – MIBI SCINTIGRAPHY TO PREDICT RESPONSE TO NEOADJUVANT
THERAPY
IN PATIENTS WITH LOCALLY ADVANCED BREAST CANCER.
Ortega Maria Eugenia, Andrés Raquel, Prats Enrique,
Lambea Julio, Lastra
Rodrigo, Mayordomo Jose Ignacio, Aguirre Elena, Ruiz
Echarri Manuel, Razola
Paula, Tardin Leticia, Millastre Esther, Tres Alejandro,
Banzo Javier / Spain
PO II / 37
MULTIMODEL SYSTEMIC TREATMENT OF A PATIENT WITH NON-FUNCTIONAL
PANCREATIC NEUROENDOCRINE TUMOR (PNET) AND INCIDENTALLY
DIAGNOSED
METACHRONOUS COLON CARCINOMA (MCC) DURING POSITRON EMISSION
TOMOGRAPHY (PET)
Binnaz DEMIRKAN, Tugba ÜNEK , Barbro ERIKSSON, Çilem
SOLAK,
Özgül SAGOL, Mehmet ALAKAVUKLAR / Turkey
PO II / 38
TREATMENT RESULTS OF PEDIATRIC OSTEOSARCOMA: LIMB SPARING
SURGERY
VERSUS AMPUTATION
Ali VARAN, Nalan YAZICI, Cemalettin AKSOY, Gökhan GEDİKOĞLU,
Bilgehan YALÇIN,
Canan AKYÜZ, Tezer KUTLUK, Münevver BÜYÜKPAMUKÇU / Turkey
PO II / 39
ANTITUMOR ACTIVITY OF LYSOMUSTINE LIPOSOMES
Lantsova Anna , Polozkova Alevtina , Shprakh Zoya ,
Peretolchina Nina ,
Oborotova Natalia, Baryshnikov Anatoly / Russia
PO II / 40
PROGNOSTIC FACTORS FOR NASOPHARYNGEAL CARCINOMA
H.ERRIHANI,S.AFQIR, N. ISMAILI, Y.SBITTI, H. M'RABTI,
Y. BENSOUDA, S.
BOUTAYEB, N. MELLAS, N. ABARROU, M.FARIK, M. ICHOU
A.MANSOURI,BENJAAFAR,EL GUEDDARI / Morroco
PO II / 41
WT1 EXPRESSION IN CHILDHOOD ACUTE LEUKEMIAS
ADRIANI SPANAKI, EMMANUELA LINARDAKIS, CHRISSOULA PERDIKOGIANNI,
EFTIHIA STIAKAKI, ALESSANDRO MOROTTI, DANIELA CILLONI,
MARIA KALMANTI / Greece
PO II / 42
SOME CONSEQUENCES OF LTSV RESULTS OF THE ISC-LUNG CANCER
STUDY GROUP FOR STAGING
Karrer, Karl (1), Berkarda, Bülent.(2), Serdengeçti,
Süheyla (2)
(1) Austria
(2) Turkey |
| Saturday, November 12, 2005 |
|
| 9:00 – 10:30 |
Session XIV Ballroom |
| Chair Persons: |
Metin Aran, İstanbul - Turkey
Gökhan Demir, İstanbul - Turkey |
| 9:00 – 9:15 |
Docetaxe , 5-Fu, Cis-Pt vs Epirubicin, 5
Fu, Cis-Pt for Advanced Gastric Carcinoma. A randomized
Clinical Trial
S. Sadighi
Tehran, Iran |
| 9:15 – 9:30 |
Factors of Prognosis in Patients With Locally
Advanced Gastric Cancer
Modassar T. Awan
Gomel, Belarus |
| 9:30 – 9:45 |
CCI-779 Plus Cis Pt is Highly Effective Against
Human Melanoma in a Mouse Xenotransplantation Model.
Christiane Thallinger
Vienna, Austria |
| 9:45 – 10:00 |
The Link Between the DNA Ploidy and Head
and Neck Cancer Patients Survival Time
T.G. Nikolaeva
Moscow, Russia |
| 10:00 – 10:30 |
Horizons in Cancer Treatment
Münir Kınay
İzmir, Turkey |
| 10:30 – 11:00 |
Coffee Break |
| 11:00 – 12:00 |
Session XV Ballroom |
| Chair Persons: |
Ahmet Özet, Ankara - Turkey
Mustafa Özgüroğlu, İstanbul - Turkey |
| 11:00 – 11:15 |
A case of Delayed Non-Hodgkyn’s Lymphoma
after High-Dose Etoposide in a Patient Underwent Autologous
Peripheral Stem Cell Transplantation for Non-Metastatic
Osteosarcoma.
Selmin Ataergin
Ankara, Turkey |
| 11:15 – 11:30 |
Transformation of Multiple Myeloma in Plasma
Cell Leukemia: Rapid Response to VAD Chemotherapy and Bortezomib
Maintenance
Selmin Ataergin
Ankara, Turkey |
| 11:30 – 11:45 |
Treatment Results of Thoracic Neuroblastomas:
A Review of
84 Cases from a Single Center
Ahmet Demir
Ankara, Turkey |
| 11:45 – 12:15 |
Current Treatment Strategies in Mesothelioma
Salih Emri
Ankara, Turkey |
| 12:15 – 12:45 |
CLOSING & AWARD SESSION Ballroom |
| |
Bülent Berkarda
President - TSC
Kurt Naber
President - ISC |
|
|
 |
